Nuclear Medicine Review
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.2 | Q4 | 21.7% | 0.281 | Q3 | 41.1% |
| 2024 | 0.7 | Q4 | 13.1% | 0.275 | Q3 | 42.8% |
| 2023 | 0.6 | Q4 | 10.0% | 0.225 | Q3 | 39.2% |
| 2022 | 0.9 | 15.1% | 0.215 | Q4 | 39.8% | |
| 2021 | — | 32.6% | 0.217 | Q4 | 41.6% | |
| 2020 | — | — | 0.216 | Q4 | 38.4% | |
| 2019 | — | — | 0.314 | Q3 | 53.8% | |
| 2018 | — | — | 0.265 | Q3 | 45.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1506-9680
ISSN
1644-4345
region
Eastern Europe
coverage
2002-2026